Albany Molecular Research (AMRI) – Private Equity
-
Albany Molecular Research (AMRI) Reports Early Termination of HSR Waiting Period for Carlyle, GTCR's Proposed Acquisition
-
Albany Molecular Research (AMRI) Agrees to Be Acquired by The Carlyle Group and GTCR for $21.75/Share
-
-
Back to AMRI Stock Lookup